KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Tax Provisions (2018 - 2019)

Inovio Pharmaceuticals (INO) has disclosed Tax Provisions for 3 consecutive years, with -$87764.0 as the latest value for Q4 2019.

  • Quarterly Tax Provisions changed N/A to -$87764.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$87764.0 through Sep 2020, up 48.24% year-over-year, with the annual reading at -$257000.0 for FY2019, 111.84% down from the prior year.
  • Tax Provisions hit -$87764.0 in Q4 2019 for Inovio Pharmaceuticals, up from -$106771.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.2 million in Q1 2018 to a low of -$1.8 million in Q3 2015.
  • Historically, Tax Provisions has averaged -$30881.7 across 3 years, with a median of -$97267.5 in 2019.
  • Biggest YoY gain for Tax Provisions was 102.89% in 2019; the steepest drop was 102.89% in 2019.
  • Year by year, Tax Provisions stood at -$308520.0 in 2015, then surged by 803.3% to $2.2 million in 2018, then plummeted by 104.04% to -$87764.0 in 2019.
  • Business Quant data shows Tax Provisions for INO at -$87764.0 in Q4 2019, -$106771.0 in Q2 2019, and -$62800.0 in Q1 2019.